Diks

Robertus Martinus M. Diks, Atvlaardingen NL

Patent application number	Description	Published
20090118359	Food product - A method for the treatment of a bioflavonoid composition, comprising the contacting of the bioflavonoid composition with ethanol of at least 90% purity at a temperature of from 10 to 80° C. for a period of at least 0.5 hour, followed by separation of the ethanol and the bioflavonoid, wherein the contacting comprises the solubilisation of the bioflavonoid in the ethanol and whereby the separation involves the recrystallisation of the bioflavonoid and whereby the contacting takes place in the presence of active carbon in an amount of 1-10 wt % based on the bioflavonoid.	05-07-2009

Patent application number	Description	Published
20080268130	Edible fat continuous spreads - The invention relates to an edible fat continuous spread comprising from 5 to 85 wt % fat and from 0.1 to 20 wt % plant sterol wherein the plant sterol is present in the form of elongated crystals. The invention further relates to a process for the preparation of an edible fat continuous spread comprising plant sterol, said process comprising the mixing of a first mixture comprising triglyceride oil and plant sterol present in the form of elongated crystals with a second mixture comprising one selected from the group consisting of fat phase, water phase and mixtures thereof, to provide a third mixture.	10-30-2008

Patent application number	Description	Published
20090036540	Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal Transduction - A method is provided for the treatment of a condition mediated by raf kinase, which includes administering a guanylhydrazone to a subject in need thereof. A method is also provided, which includes modulating or inhibiting signal transduction in a c-raf pathway with at least one guanylhydrazone. Another method is provided, which includes contacting one or more human mononuclear cells with at least one guanylhydrazone and at least one lipopolysaccharide to obtain one or more treated cells; contacting at least one selected from the group including said treated cells, one or more lysates thereof, and combinations thereof, with at least one surface-bound peptide in a surface-bound peptide array; and selectively modulating or inhibiting the phosphorylation of the surface-bound peptide.	02-05-2009